Alzheimer’s disease develops from a combination of age, genetics, and lifestyle factors that damage the brain over decades. There is no single cause. For most people, the disease results from a slow accumulation of toxic proteins in the brain, driven by a mix of risk factors that vary from person to person. About 7.4 million Americans age 65 and older are currently living with Alzheimer’s, and that number is expected to reach nearly 13 million by 2050.
What Happens Inside the Brain
Two abnormal proteins are the hallmarks of Alzheimer’s: amyloid-beta and tau. Understanding what these proteins do helps explain why the disease progresses the way it does.
Amyloid-beta is a small protein fragment that normally gets cleared from the brain. In Alzheimer’s, these fragments clump together into sticky plaques between brain cells. But it’s not the plaques themselves that do the most early damage. Smaller, soluble clusters of amyloid-beta, called oligomers, appear to be the real drivers of harm in the early stages. They interfere with the connections between neurons, disrupting the signals that form memories and guide thinking.
Tau is a protein that normally helps maintain the internal scaffolding of neurons, the tiny highway system that transports nutrients and signals from one end of a cell to the other. In Alzheimer’s, tau detaches from this scaffolding and clumps into tangled fibers inside the cell. These tangles collapse the transport system, starving the neuron of what it needs to function. Eventually, the cell dies. This process starts in memory-related areas of the brain and gradually spreads outward over years.
The Brain’s Immune System Turns Against Itself
The brain has its own immune cells, called microglia, that act as cleanup crews. Early in the disease, these cells try to protect the brain by clearing away amyloid buildup. But as the toxic proteins accumulate, microglia shift from protective mode to an aggressive, inflammatory state. They begin releasing molecules that damage surrounding neurons instead of shielding them.
This chronic inflammation becomes a self-reinforcing cycle. Inflamed microglia trigger the growth of other toxic support cells and promote synapse loss, the destruction of connections between neurons that are essential for thought and memory. Research in mouse models has shown that synapse loss and immune cell activation can actually precede tangle formation, suggesting inflammation isn’t just a consequence of Alzheimer’s but an active contributor to its progression.
Genetics: The Biggest Non-Modifiable Risk Factor
The gene that most influences Alzheimer’s risk is called APOE, and it comes in several versions. The version called APOE-e4 increases the likelihood of developing the disease and is associated with symptoms appearing at a younger age. About 15% to 25% of the population carries one copy of this gene variant, and 2% to 5% carry two copies. Having two copies raises the risk significantly more than having one. Still, carrying APOE-e4 is not a guarantee. Some people with two copies never develop Alzheimer’s, and many people who get the disease don’t carry the variant at all.
A small number of people, roughly 5% to 10% of all cases, develop what’s known as early-onset Alzheimer’s. This form is caused by inherited mutations in one of three specific genes that directly trigger overproduction of amyloid-beta. Symptoms in these families typically appear around age 45 to 47, though the range spans from the early 30s to around 60. If a parent carries one of these mutations, each child has a 50% chance of inheriting it. This form of the disease is rare but devastating, and it runs in families with a clear pattern.
How Heart Health Affects Brain Health
What’s bad for your heart turns out to be bad for your brain in very direct, biological ways. High blood pressure, diabetes, and high cholesterol don’t just raise the risk of stroke. They actively promote the production and buildup of the same toxic proteins that define Alzheimer’s.
High blood pressure reduces blood flow to the brain and weakens the blood-brain barrier, the protective lining that keeps harmful substances out of brain tissue. When this barrier breaks down, amyloid-beta production increases and the brain’s ability to clear it away decreases. This effect is especially pronounced in people who carry the APOE-e4 gene. A large imaging study found that people with both high blood pressure and the APOE-e4 variant had measurably higher amyloid levels in their brains than those with high blood pressure alone.
Diabetes has an even more striking connection. Insulin resistance, the core problem in type 2 diabetes, appears to directly stimulate one of the key enzymes that produces amyloid-beta from its precursor protein. One study found that people with diabetes had nearly four times the odds of having a positive amyloid brain scan compared to those without diabetes. The hippocampus, the brain region most critical for forming new memories, experiences a 25% reduction in glucose metabolism in Alzheimer’s patients. Some researchers have gone so far as to call Alzheimer’s “type 3 diabetes” because of how central insulin resistance appears to be in the brain’s decline.
Cholesterol plays a role too, though it’s more nuanced. Cholesterol in the brain helps shuttle the amyloid precursor protein into clusters where it gets cut into the harmful amyloid-beta fragments. This process depends on APOE, which is the brain’s main cholesterol-transporting protein, creating a direct link between cholesterol metabolism and plaque formation.
14 Risk Factors You Can Actually Change
A major 2024 report from The Lancet Commission on dementia identified 14 modifiable risk factors that, if addressed across a lifetime, could meaningfully reduce the number of people who develop dementia. These span the entire lifespan:
- Early life: Less education
- Midlife: Hearing loss, high blood pressure, obesity, traumatic brain injury, excessive alcohol consumption (more than about 12 standard US drinks per week), high LDL cholesterol
- Later life: Smoking, depression, physical inactivity, diabetes, air pollution, social isolation, untreated vision loss
Two of these, untreated vision loss and high LDL cholesterol, were added for the first time in the 2024 update based on newly compelling evidence. The list is notable for how many of the items are conditions that already have straightforward interventions: getting hearing aids, treating high blood pressure, staying physically active, maintaining social connections, and managing blood sugar.
Sleep and the Brain’s Waste Removal System
During deep sleep, the brain activates a waste-clearance network sometimes called the glymphatic system. Fluid flows through brain tissue more freely during sleep, flushing out metabolic byproducts, including amyloid-beta. This process is driven primarily by slow-wave activity during deep, non-dreaming sleep.
Chronically poor sleep disrupts this cleaning process. When the brain can’t adequately clear amyloid-beta at night, the protein accumulates in brain tissue over time, potentially accelerating the path toward Alzheimer’s. This creates a vicious cycle in people who already have early-stage disease: amyloid buildup itself disrupts sleep architecture, which further impairs clearance, which accelerates buildup. Prioritizing consistent, quality sleep is one of the more actionable ways to support the brain’s natural defenses against protein accumulation.
Why Age Matters Most
Age remains the single strongest risk factor. Alzheimer’s is rare before 65, and the likelihood roughly doubles every five years after that. This isn’t because aging “causes” Alzheimer’s, but because the brain’s repair mechanisms slow down, inflammation increases, and the cumulative effects of every other risk factor have had more time to do damage. The proteins that define the disease begin accumulating 15 to 20 years before the first symptoms appear, which means the disease process in a person diagnosed at 75 likely started in their mid-50s or earlier.
This long lead time is actually reason for optimism. It means there is a wide window, spanning decades, during which managing blood pressure, staying physically and socially active, protecting your hearing and vision, sleeping well, and controlling blood sugar can all slow the biological processes that lead to Alzheimer’s. No single factor determines who gets the disease. But the accumulation of protective choices over a lifetime meaningfully shifts the odds.